drugset / Trial / NCT04329442

Accelerated PrEP Access for Black MSM and TW

NCT04329442 ↗

NaSingle-groupOpen-labelPrevention

Summary

The investigators will pilot-test an accelerated PrEP initiation approach among young high-risk Black/African American (B/AA) men who have sex with men (MSM) and transgender women (YMSM/TW) at the point of care in community contexts.

Timeline

Start
2020-04-01
Primary completion
2021-07-31
Completion
2021-07-31

Outcome

Outcome not reported

Stopped (Enrollment): “COVID-19 caused substantial barriers to recruitment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Emtricitabine / Tenofovir Disoproxil Unknown 200 mg Oral